Gene · 7022
TFAP2C: transcription factor AP-2 gamma
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TFAP2C: transcription factor AP-2 gamma. Genes, record 7022. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7022
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q92754 | Transcription factor AP-2 gamma | 450 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents50
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 67420 | Q92754 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 179 | Q92754 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15754 | Q92754 | Espacenet |
| JP 2025521922 A | 2025-07-10 | 69 | Q92754 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 179 | Q92754 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15754 | Q92754 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15754 | Q92754 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15593 | Q92754 | Espacenet |
| JP 2024506208 A | 2024-02-09 | 117 | Q92754 | Espacenet |
| KR 1020230171424 A | 2023-12-20 | 66 | Q92754 | Espacenet |
1 to 10 of 50
See all 50 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,293
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TFAP2C papers | Newest fiscal year |
|---|---|---|---|
| P30CA086862 | Cancer Center Support Grant | 13 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 11 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 7 | 2025 |
| R24HD000836 | Laboratory of Developmental Biology | 7 | 2025 |
| R01DK018477 | Enhancer Connectomes in Regulation of Gene Expression | 6 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 5 | 2025 |
| P30CA030199 | Cancer Center Support Grant (CCSG) | 5 | 2025 |
| R01HD020676 | Trophoblast Differentiation | 5 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 4 | 2025 |
| P51OD011092 | Support for National Primate Research Center | 4 | 2025 |
1 to 10 of 1,293Source NIH's project files
See all 1,293 nih grantsPapers2,059
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| AP2-HS and a GDV1 regulatory feedback loop mediate environmental induction of sexual conversion in Plasmodium falciparum. | Nat Microbiol | 2026 | 42754706 | PubTator, text mining | PubMed |
| The RNA-binding protein La/SSB is associated with HNSCC progression and TFAP2C/FSCN1-linked transcriptional regulation. | Oncogene | 2026 | 42693251 | PubTator, text mining | PubMed |
| Molecular Regulation of Primordial Germ Cell Specification and Implications for In Vitro Gametogenesis. | Biol Reprod | 2026 | 42691131 | PubTator, text mining | PubMed |
| Dual MDM2 and PPARG regulatory axes mediate the antiepileptic effects of Gouteng: An integration of bioinformatics, network pharmacology, machine learning, molecular docking, and MD simulations. | Neuropharmacology | 2026 | 42575349 | PubTator, text mining | PubMed |
| TRIM37 interacts with TRIM28 to maintain primordial germ cell identity during migration. | Cell Res | 2026 | 42533095 | PubTator, text mining | PubMed |
| Identification of a sequence element regulating H3K9 methylation at the ap2-g locus in Plasmodium falciparum. | Sci Rep | 2026 | 42443261 | PubTator, text mining | PubMed |
| Identification of hub mRNAs and long non-coding RNAs involved in temozolomide-resistant glioblastoma (brain cancer) cell lines. | Discov Oncol | 2026 | 42247190 | PubTator, text mining | PubMed |
| Super-enhancer-driven ITGB2-AS1 promotes ovarian cancer progression by binding to IQGAP1. | Transl Oncol | 2026 | 42241993 | PubTator, text mining | PubMed |
| Deciphering the Transcription Factor-Dominated Ecosystem During Esophageal Squamous Cell Carcinoma Progression at the Single-Cell Level. | Int J Mol Sci | 2026 | 42196406 | PubTator, text mining | PubMed |
| Epithelial YPEL3 Modulates CD8+ T-Cell Infiltration and Tumor Progression Through CREB1-CXCL16 Signaling in HNSCC. | Cancer Sci | 2026 | 42186216 | PubTator, text mining | PubMed |
1 to 10 of 2,059
See all 2,059 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/7022
GET https://conductscience.org/api/genes/v1/7022/patents?page=2